Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01135498 | A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | completed | Phase 2 | 90 | Hoffmann-La RocheINDUSTRY | 1 | Feb 6, 2015 | clinicaltrials |
| NCT02195141 | Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer | unknown | Phase 2 | 104 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01269216 | A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer | completed | Phase 2 | 136 | Yonsei UniversityOTHER | 1 | Jan 28, 2015 | clinicaltrials |
| NCT00660582 | FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor | completed | Phase 2 | 152 | Per PfeifferOTHER | 3 | Jan 21, 2015 | clinicaltrials |
| NCT01483001 | Feasibility Study on Stem Cells Sensitivity Assay(STELLA) | completed | Phase 2 | 23 | Associazione Oncologia TraslazionaleOTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT00754494 | Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 6, 2015 | clinicaltrials |
| NCT01659424 | Phase II Trial of Preoperative High-dose-rate Endorectal Brachytherapy and FOLFOX Chemotherapy for Rectal Cancer(HDRBT) | withdrawn | Phase 2 | 0 | Beth Israel Medical CenterOTHER | 1 | Dec 18, 2014 | clinicaltrials |
| NCT01077739 | A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | completed | Phase 2 | 75 | Hoffmann-La RocheINDUSTRY | 1 | Dec 15, 2014 | clinicaltrials |
| NCT00865709 | Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects | completed | Phase 2 | 198 | BayerINDUSTRY | 10 | Dec 11, 2014 | clinicaltrials |
| NCT00704600 | Nelfinavir, a Phase I/Phase II Rectal Cancer Study(Nelfinavir) | completed | Phase 1 / Phase 2 | 15 | Maastricht Radiation OncologyOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT01472770 | A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer(GemCaP) | completed | Phase 2 | 49 | Vejle HospitalOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT00376909 | A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women | completed | Phase 2 | 2,729 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01889680 | Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer | withdrawn | Phase 2 | 0 | NSABP Foundation IncNETWORK | 0 | Dec 2, 2014 | clinicaltrials |
| NCT02288078 | Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402) | unknown | Phase 2 | 74 | Clinical Research Support Center KyushOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01554059 | Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients(New Beat) | completed | Phase 2 | 25 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 10, 2014 | clinicaltrials |
| NCT02280070 | RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). | unknown | Phase 2 | 110 | Clinical Research Support Center KyushOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT01378143 | Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy | completed | Phase 2 | 53 | Oncozyme Pharma Inc.INDUSTRY | 1 | Oct 21, 2014 | clinicaltrials |
| NCT02268006 | IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment(BISER) | unknown | Phase 2 | 50 | Institute of Oncology LjubljanaOTHER | 1 | Oct 20, 2014 | clinicaltrials |
| NCT02032485 | Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer(OC-AP-ICG-IV) | completed | Phase 2 | 10 | Jules Bordet InstituteOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT00390364 | Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy | terminated | Phase 2 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 8, 2014 | clinicaltrials |
| NCT01149434 | Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers | terminated | Phase 1 / Phase 2 | 19 | University of UtahOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT00642746 | Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC) | terminated | Phase 2 | 16 | OHSU Knight Cancer InstituteOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT01525056 | Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI | completed | Phase 2 | 30 | London Health Sciences CentreOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT01186263 | Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy(EXPLOSIVE) | completed | Phase 2 | 24 | University of MagdeburgOTHER | 1 | Sep 4, 2014 | clinicaltrials |
| NCT00416494 | Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer | completed | Phase 2 | 50 | Herbert Hurwitz, MDOTHER | 0 | Sep 3, 2014 | clinicaltrials |
| NCT02216487 | Trial of FOLF(HA)Iri With Cetuximab in mCRC(Chime) | unknown | Phase 2 | 45 | Western General Hospital, AustraliaOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT02228785 | A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer(CC1C) | terminated | Phase 2 | 5 | Cancer Advances Inc.INDUSTRY | 0 | Aug 29, 2014 | clinicaltrials |
| NCT00538291 | Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment | terminated | Phase 2 | 13 | City of Hope Medical CenterOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT01365910 | Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer | terminated | Phase 2 | 30 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 26, 2014 | clinicaltrials |
| NCT01159171 | A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. | completed | Phase 2 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Aug 15, 2014 | clinicaltrials |
| NCT00514761 | Phase II Efficacy Study of AZD6244 in Colorectal Cancer | completed | Phase 2 | 64 | AstraZenecaINDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT00125034 | Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)(OPUS) | completed | Phase 2 | 344 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 13 | Aug 7, 2014 | clinicaltrials |
| NCT01105377 | Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Aug 1, 2014 | clinicaltrials |
| NCT02204332 | Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment(COMETA) | terminated | Phase 2 | 38 | Hospital Clinico Universitario de SantiagoOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT00159432 | Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer | completed | Phase 2 | 63 | University of Southern CaliforniaOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01181609 | A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | completed | Phase 2 | 54 | Hoffmann-La RocheINDUSTRY | 1 | Jul 28, 2014 | clinicaltrials |
| NCT01198548 | High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer | terminated | Phase 2 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT00393822 | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | completed | Phase 2 / Phase 3 | 100 | AmgenINDUSTRY | 0 | Jul 15, 2014 | clinicaltrials |
| NCT01418742 | SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment | terminated | Phase 2 | 11 | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbHOTHER | 1 | Jul 14, 2014 | clinicaltrials |
| NCT00044343 | GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin | completed | Phase 2 | 80 | GlaxoSmithKlineINDUSTRY | 2 | Jul 10, 2014 | clinicaltrials |
| NCT01205711 | Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer(FOLFERA) | completed | Phase 2 | 111 | Cardiff UniversityOTHER | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00107315 | Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | 16 | Roswell Park Cancer InstituteOTHER | 1 | Jul 4, 2014 | clinicaltrials |
| NCT02181465 | Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.(CC1A&B) | completed | Phase 2 | 11 | Cancer Advances Inc.INDUSTRY | 1 | Jul 4, 2014 | clinicaltrials |
| NCT00165854 | Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eisai LimitedINDUSTRY | 3 | Jun 27, 2014 | clinicaltrials |
| NCT00439517 | Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.(FUTURE) | completed | Phase 2 | 302 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 14 | Jun 27, 2014 | clinicaltrials |
| NCT02177084 | Percutaneous Tibial Nerve Stimulation in the Treatment of Anterior Resection Syndrome After Rectal Cancer Surgery | unknown | Phase 2 | 12 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jun 27, 2014 | clinicaltrials |
| NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | completed | Phase 2 | 58 | Roswell Park Cancer InstituteOTHER | 1 | Jun 23, 2014 | clinicaltrials |
| NCT01208194 | Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma(IMPACT) | completed | Phase 2 | 59 | Mologen AGINDUSTRY | 6 | Jun 20, 2014 | clinicaltrials |
| NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 2 | Jun 17, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Feb 6, 2015source: clinicaltrials